Medical Science Liaison, Switzerland

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated field medical professional to join our team as Medical Science Liaison, Oncology, Switzerland. This role will execute approved field medical plans within an assigned Swiss territory, engage in peer-to-peer scientific exchange with healthcare professionals, gather and communicate medical insights, support clinical study site and investigator engagement, and contribute to medical education, advisory boards, and congress activities under the direction of the Medical Director, Switzerland.

Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development.

The individual will collaborate with stakeholders within medical affairs and across the organization, including but not limited to Clinical Development, Commercial, Program Management, Clinical Operations, and Compliance teams. The ideal candidate is an effective communicator, driven, detail-oriented, proactive, and a skilled collaborator. The role is an individual contributor position with no direct line-management accountability.

The MSL contributes field insights and scientific expertise to support the Swiss medical plan but does not own country medical strategy, governance, budget, or team leadership. Required Skills, Experience and Education: Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge. Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions.

Collect, document, synthesize, and communicate field medical insights from KOLs and HCPs to the Medical Director and relevant internal teams. Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities. Establish credibility as a scientific expert and resource for internal stake holders, providing medical and scientific support for assigned products and therapeutic areas and territory.

Collaborate cross-functionally with Medical Affairs, Clinical Development, Commercial, Clinical Operations, and Compliance to support execution of approved medical strategies and tactics. Stay current with scientific literature, emerging research, and competitive landscape. Adhere to Revolution Medicines Core Values and policies.

Requirements

for customer engagement by field-based employees. Execute the approved Swiss field medical engagement plan for assigned accounts and stakeholders.

. Support onboarding and informal coaching